IMMUNE RESPONSE IN MALIGNANT GLIOMA

Objective: Malignant gliomas are primary brain tumors with excessive mortality and high resistance to chemotherapy and radiotherapy. The survival time for glioblastoma multi­forme is about 6-12 months. As key pathogenetic mechanisms are recognized the massive necrosis, angiogenesis and hypoxia withi...

Full description

Bibliographic Details
Main Authors: Iliyan Koev, E. Slavov, D. Staykov, K. Halacheva, Victoria Sarafian
Format: Article
Language:English
Published: Peytchinski Publishing 2010-07-01
Series:Journal of IMAB
Subjects:
Online Access:http://www.journal-imab-bg.org/statii-10/vol16_b3_p17-19.pdf